In Q1 2025, The Clorox Company reported a record revenue of $1.762 billion, reflecting a 27.13% increase year-over-year, despite a 7.41% decrease from the prior quarter. This growth was driven by strong consumer demand for the company’s health and wellness product lines amid the ongoing recovery from pandemic-driven disruptions. Net income surged to $99 million, showcasing a remarkable 350% year-over-year increase, although a notable 54.17% decline from the previous quarter. The earnings per share (EPS) reached $0.80, nearly quadrupling compared to last year, indicating strong profitability despite seasonally weaker sales observed in Q2. The management emphasized the resilience demonstrated by operational adjustments and strategic scaling in marketing and product development, setting a positive tone for the rest of the fiscal year.